Long-term immunologic induction of donor-specific tolerance to skin allografts by bone marrow transplant in rabbits

Plastic and Reconstructive Surgery

Volumn 111, Issue 1, 2003, Pages 291-297

  Wang, Yi Biao ^a   Ogawa, Yutaka ^a   Doi, Hideaki ^a   Kusumoto, Kenji ^a   Jin, Tie Nan ^a   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DONOR; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RABBIT; SKIN ALLOGRAFT; SURVIVAL TIME; VEIN;

EID: 0037216746     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-200301000-00049     Document Type: Article

References (16)

1. Rayfield, L. S., and Brent, L. Tolerance, immunocompetence, and secondary disease in fully allogeneic radiation chimeras. Transplantation 36: 183, 1983.
2. Iidstad, S. T., and Sachs, D. H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307: 168, 1984.
3. Helg, C., Chapuis, B., Bolle, J. F., et al. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation. Transplantation 58: 1420, 1994.
4. Ikehara, S. New strategies for allogeneic bone marrow transplantation and organ allografts. Acta Haematol. 101: 68, 1999.
5. Dubernard, J. M., Owen, E., Herzberg, G., et al. Human hand allograft: Report on first 6 months. Lancet 353: 1315, 1999.
6. Ikehara, S. Bone marrow transplantation for autoimmune diseases. Acta Haematol. 99: 116, 1998.
7. Cobbold, S. P., Martin, G., Qin, S., and Waldmann, H. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 323: 164, 1986.
8. Sharabi, Y., and Sachs, D. H. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J. Exp. Med. 169: 493, 1989.
9. Jin, T., Sugiura, K., Ishikawa, J., et al. Persistent tolerance induced after portal venous injection of allogeneic cells plus cyclophosphamide treatment. Immunobiology 200: 215, 1999.
10. Yu, X. Z., Bidwell, S. J., Martin, P. J., and Anasetti, C. CD28-specific antibody prevents graft-versus-host disease in mice. J. Immunol. 164: 4564, 2000.
11. Hale, G., Zhang, M.J., Bunjes, D., et al. Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection. Blood 92: 4581, 1998.
12. Storb, R., Raff, R. F., Appelbaum, F. R., et al. FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors. Transplantation 56: 800, 1993.
13. Hoffman, A. L., Makowka, L., Banner, B., et al. The use of FK-506 for small intestine allotransplantation: Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation 49: 483, 1990.
14. Morita, H., Sugiura, K., Nagahama, T., et al. Acceptance of skin xenografts (from guinea pig to mice) by portal venous and intravenous injections of donor hematolymphoid cells. Transplant. Proc. 32: 293, 2000.
15. Kushida, T., Inaba, M., Takeuchi, K., Sugiura, K., Ogawa, R., and Ikehara, S. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation. Blood 95: 1862, 2000.
16. Duerst, R. E., Horan, J. T., Liesveld, J. L., et al. Allogeneic bone marrow transplantation for children with acute leukemia: Cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide. Bone Marrow Transplant. 25: 489, 2000.